Background Surgical resection for intraductal papillary mucinous neoplasm (IPMN) of the
pancreas has increased over the last decade. While IPMN with main duct communication …

Objective: The 2012 international consensus guidelines for the management of intraductal
papillary mucinous neoplasms (IPMN) recommend surgical treatment in main-duct IPMN …

Background Although the natural history of intraductal papillary mucinous neoplasm (IPMN)
remains unclear, large surgical series have reported malignancy in 40% to 90% of main …

The current treatment strategy for intraductal papillary mucinous neoplasms (IPMNs), based
on the international consensus guideline, has been accepted widely. However, reported …

AIM: To compare characteristics and outcomes of resected and nonresected main-duct and
mixed intraductal papillary mucinous neoplasms of the pancreas (IPMN). METHODS: Over a …

Purpose The clinical importance of intraductal papillary mucinous neoplasm of the pancreas
(IPMN) has been increasing with a large number of newly diagnosed IPMN. This study was …

Objective: The aim of this study was to evaluate existing management guidelines for branch-
duct intraductal papillary mucinous neoplasms (IPMNs). Background: According to current …

Abstract Background and Aim The evidence for main pancreatic duct intraductal papillary
mucinous neoplasms (MPD‐IPMN) malignancy is based predominantly on investigation of …

Objectives We examined long-term outcomes in patients with surgically treated intraductal
papillary mucinous neoplasm (IPMN) to determine if any clinical or histologic features could …

Main pancreatic duct (MPD) involvement is a well-demonstrated risk factor for malignancy in
intraductal papillary mucinous neoplasm (IPMN). Preoperative radiographic determination of …